Jochen Schmitt

Active 2003–2025

211
Papers
20,087
Citations
80
h-index
192
i10-index

Citations

Citations per year for Jochen Schmitt1986: 1 citations1995: 2 citations2004: 1 citations2005: 4 citations2006: 5 citations2007: 15 citations2008: 22 citations2009: 46 citations2010: 81 citations2011: 63 citations2012: 103 citations2013: 128 citations2014: 113 citations2015: 108 citations2016: 158 citations2017: 191 citations2018: 187 citations2019: 674 citations2020: 700 citations2021: 665 citations2022: 641 citations2023: 574 citations2024: 885 citations2025: 324 citations2026: 9 citations1987–1994: no citations, so these years are not shown1996–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,419 citing papers, 14.5% of this breakdownUnited Kingdom: 1,036 citing papers, 10.6% of this breakdownGermany: 875 citing papers, 8.9% of this breakdownCanada: 487 citing papers, 5% of this breakdownNetherlands: 481 citing papers, 4.9% of this breakdownItaly: 405 citing papers, 4.1% of this breakdownAustralia: 359 citing papers, 3.6% of this breakdownChina: 348 citing papers, 3.5% of this breakdownFrance: 331 citing papers, 3.4% of this breakdownSpain: 303 citing papers, 3.1% of this breakdownSwitzerland: 293 citing papers, 3% of this breakdownDenmark: 283 citing papers, 2.9% of this breakdown
0%14.5%Other 32.5%

Fields

  • Medicine69.2%
  • Immunology and Microbiology8.2%
  • Social Sciences6.8%
  • Health Professions4.3%
  • Biochemistry, Genetics and Molecular Biology3%
  • Psychology1.5%
  • Other7%

Topics

  • Dermatology and Skin Diseases11.5%
  • Allergic Rhinitis and Sensitization5.5%
  • Psoriasis: Treatment and Pathogenesis5.5%
  • Asthma and respiratory diseases4.3%
  • Delphi Technique in Research3.1%
  • Food Allergy and Anaphylaxis Research2.4%
  • Other67.7%

Coauthors

All papers

Open in search
  1. The COMET Handbook: version 1.0

    Authors: , , , , , , , , , , , , , , , - Trials 2017 cited by 2,003

  2. Core Outcome Set–STAndards for Reporting: The COS-STAR Statement

    Authors: , , , , , , , , , , , - PLoS Medicine 2016 cited by 650

  3. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frederikus A. Klok, С. Н. Авдеев, Charitini Stavropoulou, Melina Michelen, Olalekan Lee Aiyegbusi, Melanie Calvert, Sarah Hughes, Shamil Haroon, Laura Fregonese, Gail Carson, Samuel Knauß, Margaret O’Hara, John M. Marshall, Margaret S. Herridge, Srinivas Murthy, Theo Vos, Sarah Wulf Hanson, Ann M. Parker, Kelly K. O’Brien, Andrea Lerner, Jennifer Chevinsky, Elizabeth R. Unger, Robert W. Eisinger, Catherine L. Hough, Sharon Saydah, Jennifer Frontera, Régis Goulart Rosa, Bin Cao, Shinjini Bhatnagar, Ramachandran Thiruvengadam, Archana Seahwag, Anouar Bouraoui, Maria D. Van Kerkhove, Tarun Dua, Pryanka Relan, Juan Soriano Ortiz - The Lancet Respiratory Medicine 2022 cited by 231

  4. Systemic Immunomodulatory Treatments for Atopic Dermatitis

    Authors: , , , , , , , , , , , - JAMA Dermatology 2022 cited by 165

  5. Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Rheumatology 2023 cited by 122

  6. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jochen Walker, Christa Scheidt‐Nave, Jochen Schmitt - PLoS Medicine 2022 cited by 131

  7. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2017 cited by 236

  8. The HOME Core outcome set for clinical trials of atopic dermatitis

    Authors: , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 151

  9. Atopic dermatitis displays stable and dynamic skin transcriptome signatures

    Authors: , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 128

  10. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference

    Authors: , , , , , - Allergy 2011 cited by 382

  11. Association between aircraft, road and railway traffic noise and depression in a large case-control study based on secondary data

    Authors: , , , , , , , , , - Environmental Research 2016 cited by 155

  12. Systemic Immunomodulatory Treatments for Atopic Dermatitis

    Authors: , , , , , , , , , , , , , - JAMA Dermatology 2024 cited by 76

  13. Skin care interventions in infants for preventing eczema and food allergy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cochrane Database of Systematic Reviews 2022 cited by 68

  14. Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manoj Sivan, Charitini Stavropoulous - The Lancet Respiratory Medicine 2023 cited by 60

  15. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials

    Authors: , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2014 cited by 314

  16. Comparison of different rating scales for the use in Delphi studies: different scales lead to different consensus and show different test-retest reliability

    Authors: , , , , , , , , - BMC Medical Research Methodology 2020 cited by 194

  17. Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis

    Authors: , , , , , , , , , , , , , , - Allergy 2020 cited by 121

  18. Blood transcriptome profiling identifies 2 candidate endotypes of atopic dermatitis

    Authors: , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 57

  19. Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate‐to‐severe atopic dermatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Allergy 2023 cited by 44

  20. Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis

    Authors: , , , , , , , , , , , , , - JAMA Dermatology 2020 cited by 159

  21. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luis Felipe Reyes, A. I. Asmanov, Margaret O’Hara, J. T. Scott, Melina Michelen, Charitini Stavropoulou, John O. Warner, Margaret S. Herridge, Paula Williamson - BMC Medicine 2022 cited by 145

  22. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Authors: , , , , , , , , , , , , , , , , , , , , - Cochrane Database of Systematic Reviews 2011 cited by 826

  23. What are the best outcome measurements for atopic eczema? A systematic review

    Authors: , , - Journal of Allergy and Clinical Immunology 2007 cited by 388

  24. Skin care interventions in infants for preventing eczema and food allergy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cochrane Database of Systematic Reviews 2021 cited by 98